Peter Colabuono
Principal at Decheng Capital, CEO of Ariagen, and a board director of Checkmate Pharmaceuticals.
Companies
Company
Roles
Checkmate Pharmaceuticals
Checkmate Pharmaceuticals is a Cambridge, Massachusetts-based biopharmaceutical company focused on the activation of the innate immune system to treat cancer. The company was acquired by Regeneron in May 2022.
Board Member